CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Option exercise | +75,000 | $21.58 | $1.6M | 598,478 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Sale | −75,000 | $100.12 | $7.5M | 523,478 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −75,000 | 225,000 | ||
| 2026-05-08 | Giraudo Bryan Director | Sale | −6,000 | $100.00 | $600K | 0 |
| 2026-05-08 | Giraudo Bryan Director | Sale | −5,130 | $100.00 | $513K | 12,695 |
| 2026-05-07 | Giraudo Bryan Director | Option exercise | +24,000 | $6.45 | $155K | 31,825 |
| 2026-05-07 | Giraudo Bryan Director | Option exercise | +12,000 | $6.98 | $84K | 43,825 |
| 2026-05-07 | Giraudo Bryan Director | Sale | −36,000 | $100.14 | $3.6M | 27,825 |
| 2026-05-07 | Giraudo Bryan Director | Sale | −12,000 | $100.07 | $1.2M | 6,000 |
| 2026-05-07 | Giraudo Bryan Director | Option exercise · Stock Option (right to buy) | −24,000 | 0 | ||
| 2026-05-07 | Giraudo Bryan Director | Option exercise · Stock Option (right to buy) | −12,000 | 0 | ||
| 2026-04-23 | PATEL DINESH V PH D President and CEO | Gift | −1,460 | 523,478 | ||
| 2026-04-20 | Ali Asif Chief Financial Officer | Sale | −1,750 | $105.47 | $185K | 59,003 |
| 2026-03-26 | MOLINA ARTURO MD Chief Medical Officer | Option exercise | +15,000 | $8.04 | $121K | 99,115 |
| 2026-03-26 | MOLINA ARTURO MD Chief Medical Officer | Sale | −15,000 | $104.79 | $1.6M | 84,115 |
| 2026-03-26 | MOLINA ARTURO MD Chief Medical Officer | Option exercise · Stock Option (right to buy) | −15,000 | 50,971 | ||
| 2026-03-26 | SELICK HAROLD E Director | Option exercise | +24,000 | $12.88 | $309K | 84,845 |
| 2026-03-26 | SELICK HAROLD E Director | Sale | −24,000 | $105.00 | $2.5M | 60,845 |
| 2026-03-26 | SELICK HAROLD E Director | Option exercise · Stock Option (right to buy) | −24,000 | 0 | ||
| 2026-03-26 | Ali Asif Chief Financial Officer | Option exercise | +19,500 | $19.19 | $374K | 80,253 |
Page 3 of 29 · 580 trades